Clinical trial

Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)

NCT00395603

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2006-09-01

PhasePHASE3

Study timeline

Study start (unknown)2006-09-01Date precision: month

Registry last updated2024-08-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cardiovascular Diseasesunresolved

Diabetes Mellitusverified · MONDO: diabetes mellitus

Interventions

MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 6 WeeksDRUG

Comparator: atorvastatin / Duration of Treatment: 6 WeeksDRUG

Sponsors & collaborators

Organon and Colead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00395603 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.